VSTM

Verastem, Inc.

Catalyst Confirmed

AVMAPKI FAKZYNJA CO-PACK

KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC)

Resolved

146days ago

Catalyst readout · Feb 11, 2026

What's at stake A key catalyst for AVMAPKI FAKZYNJA CO-PACK (KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC)) is expected Feb 11, 2026.

Primary source · SEC 8-K verified 15h ago

“Leadership to participate in a fireside chat at the Guggenheim Emerging Outlook Conference in New York City on February 11, 2026”

Add to calendar Post on X Reddit

Provenance